Genome-wide association study identifies five susceptibility loci for glioma

To identify risk variants for glioma, we conducted a meta-analysis of two genome-wide association studies by genotyping 550K tagging SNPs in a total of 1,878 cases and 3,670 controls, with validation in three additional independent series totaling 2,545 cases and 2,953 controls. We identified five r...

Full description

Saved in:
Bibliographic Details
Published inNature genetics Vol. 41; no. 8; pp. 899 - 904
Main Authors Hemminki, Kari, Andersson, Ulrika, Bergenheim, A Tommy, Linnebank, Michael, Ahlbom, Anders, Hosking, Fay J, Idbaih, Ahmed, Lau, Ching, Dobbins, Sara E, Schramm, Johannes, Houlston, Richard S, Muir, Kenneth, Lönn, Stefan, Price, Amy, Shete, Sanjay, Feychting, Maria, Malmer, Beatrice, Simon, Matthias, Schoemaker, Minouk, Marie, Yannick, Robertson, Lindsay B, Hoang-Xuan, Khe, Liu, Yanhong, Boisselier, Blandine, Lathrop, Mark, Kumar, Rajiv, Swerdlow, Anthony, Sanson, Marc, Yu, Robert, Henriksson, Roger, Hallani, Soufiane El, Delattre, Jean-Yves, Gu, Xiangjun, Bondy, Melissa, Hepworth, Sarah J, Zelenika, Diana, Armstrong, Georgina
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.08.2009
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To identify risk variants for glioma, we conducted a meta-analysis of two genome-wide association studies by genotyping 550K tagging SNPs in a total of 1,878 cases and 3,670 controls, with validation in three additional independent series totaling 2,545 cases and 2,953 controls. We identified five risk loci for glioma at 5p15.33 (rs2736100, TERT; P = 1.50 × 10−17), 8q24.21 (rs4295627, CCDC26; P = 2.34 × 10−18), 9p21.3 (rs4977756, CDKN2A-CDKN2B; P = 7.24 × 10−15), 20q13.33 (rs6010620, RTEL1; P = 2.52 × 10−12) and 11q23.3 (rs498872, PHLDB1; P = 1.07 × 10−8). These data show that common low-penetrance susceptibility alleles contribute to the risk of developing glioma and provide insight into disease causation of this primary brain tumor.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ISSN:1061-4036
1546-1718
1546-1718
DOI:10.1038/ng.407